Dividend
-
-
-
-
-
-
-
Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth
-
-
-
-
-
-
-
Takeda Delivers Strong Revenue and Profit Growth in FY2022; Updated Capital Allocation Policy Reflects Deleveraging Progress and Confidence in Growth Outlook
-
-
-
-
-
-
-
Takeda Pharmaceutical (TAK) Reports Q3 EPS of JPY 154
-
-
-
-
-
-
-
Takeda FY2020 Q3 Results Demonstrate Growth Acceleration and Continued Resilience; Full-Year Management Guidance for FY2020 Confirmed, Forecast Raised for Free Cash Flow and Reported EPS
-
-
-
-
-
-
-
Takeda Reports Solid Second Quarter FY2019 Results and Raises Profit Guidance for the Full Year
-
-
445,269 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

